Cargando…
Structure of the catalytic domain of the colistin resistance enzyme MCR-1
BACKGROUND: Due to the paucity of novel antibiotics, colistin has become a last resort antibiotic for treating multidrug resistant bacteria. Colistin acts by binding the lipid A component of lipopolysaccharides and subsequently disrupting the bacterial membrane. The recently identified plasmid-encod...
Autores principales: | Stojanoski, Vlatko, Sankaran, Banumathi, Prasad, B. V. Venkataram, Poirel, Laurent, Nordmann, Patrice, Palzkill, Timothy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031297/ https://www.ncbi.nlm.nih.gov/pubmed/27655155 http://dx.doi.org/10.1186/s12915-016-0303-0 |
Ejemplares similares
-
Deep Mutational Scanning Reveals the Active-Site Sequence Requirements for the Colistin Antibiotic Resistance Enzyme MCR-1
por: Sun, Zhizeng, et al.
Publicado: (2021) -
Mapping the determinants of catalysis and substrate specificity of the antibiotic resistance enzyme CTX-M β-lactamase
por: Judge, Allison, et al.
Publicado: (2023) -
National survey of colistin resistance among carbapenemase-producing Enterobacteriaceae and outbreak caused by colistin-resistant OXA-48-producing Klebsiella pneumoniae, France, 2014
por: Jayol, Aurélie, et al.
Publicado: (2016) -
Catalytic mechanism of the colistin resistance protein MCR-1
por: Suardíaz, Reynier, et al.
Publicado: (2021) -
Mutagenesis and structural analysis reveal the CTX-M β-lactamase active site is optimized for cephalosporin catalysis and drug resistance
por: Lu, Shuo, et al.
Publicado: (2023)